Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Reported revenue from operations up by 11% to Rs. 944 crores Reported PAT (after exceptional items) up by 18% to Rs. 131 crore
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535
Aims to become India’s leading cancer testing company
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Subscribe To Our Newsletter & Stay Updated
